Form 4 for EYPT EyePoint, Inc.
Accepted 2022-02-11 00:00:00 ET · period of report 2022-02-09 · accession 0001562180-22-001413 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-11 | 2022-02-09 | EYPT | Paggiarino Dario A. | Chief Medical Off | F - Tax | $10.13 | -1,721 | 15.8K | -10% | -$17.4K |
| D | 2022-02-11 | 2022-02-09 | EYPT | Paggiarino Dario A. | Chief Medical Off | M - OptEx | $0.00 | +4,966 | 17.6K | +39% | $0 |
| D | 2022-02-11 | 2022-02-09 | EYPT | Paggiarino Dario A. | Chief Medical Off | M - OptEx | $0.00 | -4,966 | 9,934 | -33% | $0 |
| DM | 2022-02-11 | 2022-02-09 | EYPT | Paggiarino Dario A. | Chief Medical Off | A - Grant | $0.00 | +87.5K | 17.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-09 | F | D | 1,721 | $10.13 | 15,840 | D | — | — | (F1) No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units |
| 2 | Common | Common Stock | 2022-02-09 | M | A | 4,966 | $0.00 | 17,561 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2022-02-09 | M | D | 4,966 | $0.00 | 9,934 | D | $0.00 · — to — | 4,966 Common Stock | (F3) The restricted stock units vest in three ratable annual installments beginning February 9, 2022. |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-02-09 | A | A | 70,000 | $0.00 | 70,000 | D | $10.13 · — to 2032-02-09 | 70,000 Common Stock | (F4) The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2023 and the remainder ratably, on a monthly basis, over the remaining three years. |
| 5 | Derivative | Restricted Stock Units | 2022-02-09 | A | A | 17,500 | $0.00 | 17,500 | D | $0.00 · — to — | 17,500 Common Stock | (F2) The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. |